Key Points
- On January 6, Cosmos Health CEO Grigorios Siokas bought 133,953 shares at an average price of $0.54 for $72,334.62, raising his direct stake to 6,850,724 shares (a 1.99% increase).
- Siokas has been steadily accumulating stock since November with multiple purchases (including 168,472 shares at $0.42 on December 15), signaling sustained insider buying.
- Cosmos Health trades around $0.52 with a market cap of about $19.5M, reported negative earnings and a volatile price range ($0.28–$1.32 over 52 weeks), and carries an average "Sell" analyst rating.
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 133,953 shares of the company's stock in a transaction dated Tuesday, January 6th. The stock was acquired at an average cost of $0.54 per share, for a total transaction of $72,334.62. Following the completion of the acquisition, the chief executive officer directly owned 6,850,724 shares in the company, valued at approximately $3,699,390.96. The trade was a 1.99% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.
Grigorios Siokas also recently made the following trade(s):
- On Friday, December 19th, Grigorios Siokas purchased 88,314 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.49 per share, for a total transaction of $43,273.86.
- On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The shares were bought at an average cost of $0.42 per share, for a total transaction of $70,758.24.
- On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The shares were bought at an average price of $0.64 per share, with a total value of $48,870.40.
- On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.63 per share, with a total value of $35,111.16.
- On Friday, November 21st, Grigorios Siokas acquired 56,080 shares of Cosmos Health stock. The stock was purchased at an average price of $0.68 per share, with a total value of $38,134.40.
- On Thursday, November 20th, Grigorios Siokas purchased 51,315 shares of Cosmos Health stock. The stock was bought at an average cost of $0.62 per share, for a total transaction of $31,815.30.
- On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.65 per share, for a total transaction of $40,049.10.
Cosmos Health Trading Down 3.2%
Shares of COSM opened at $0.52 on Thursday. The firm's fifty day moving average is $0.59 and its two-hundred day moving average is $0.73. The stock has a market cap of $19.48 million, a PE ratio of -0.69 and a beta of 5.37. The company has a quick ratio of 0.84, a current ratio of 0.99 and a debt-to-equity ratio of 0.25. Cosmos Health Inc. has a 52-week low of $0.28 and a 52-week high of $1.32.
Cosmos Health (NASDAQ:COSM - Get Free Report) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%.The business had revenue of $17.11 million during the quarter, compared to analysts' expectations of $16.40 million. Research analysts forecast that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the stock. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Cosmos Health in a research report on Wednesday, October 8th. Wall Street Zen raised Cosmos Health to a "hold" rating in a report on Saturday, September 20th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cosmos Health presently has an average rating of "Sell".
View Our Latest Stock Analysis on COSM
Hedge Funds Weigh In On Cosmos Health
An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC raised its stake in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 133.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 225,507 shares of the company's stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.
Cosmos Health Company Profile
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
